Identification of Phytochemical Inhibitors Targeting VEGFA and TGFBR2 of Cervical Cancer: Insights from Virtual Screening, ADMET and DFT Studies

Tanzil Juneja,Joydeep Chakraborty,Khushal Kapadiya,Jignesh H. Kamdar
DOI: https://doi.org/10.1002/slct.202304901
2024-04-28
ChemistrySelect
Abstract:This study identifies potential phytochemical inhibitors for Vascular Endothelial Growth Factor A (VEGFA) and Transforming Growth Factor Beta type II receptor (TGFBR2) in cervical cancer treatment. Two Spirosolane, and Ginkgetin were identified based on binding affinity, ADMET and DFT studies. The findings of this study have the potential to contribute to the formulation of innovative therapeutic approaches for both treating and preventing cervical cancer. The vascular endothelial growth factor A (VEGFA) and Transforming Growth Factor Beta type II receptor (TGFBR2) serves as a promising candidate in the treatment of cervical cancer, playing a crucial role in angiogenesis and tumorigenesis. Its involvement in cervical cancer has been well documented. The pursuit of phytochemical inhibitors to counteract the cancer promoting effects of VEGFA and TGFBR2 has gained considerable momentum as very few drugs are available. In this study, we employed computational techniques to identify potential VEGFA and TGFBR2 inhibitors from 101 phytochemicals. The Spirosolane, Withaferin A & Silybin B for VEGFA and Ginkgetin, Hesperedin for TGFBR2 were identified as promising candidates as indicated by their favorable docking scores and robust energy profiles. Furthermore, Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profile indicating that Spirosolane and Ginkgetin exhibit favorable drug‐like properties and medicinal chemistry characteristics, suggesting their potential as novel drug candidates. The Density Functional Theory (DFT) studies revealed that these compounds exhibited the highest electrophilicity index for occupied molecular orbitals, basicity, and dipole moment, all contributing to their stability and strong binding affinity at the active site. To advance this line of research, additional experimental validation is warranted to facilitate the development of highly selective and effective VEGFA and TGFBR2 inhibitors.
chemistry, multidisciplinary
What problem does this paper attempt to address?